Chronic, low-level exposure to the cholinesterase inhibitor DFP. II. Time course of behavioral state changes in rats

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 1, 1999, Pages 105-114

  Deurveilher, Samuel ^a   Hars, Bernard ^a   Hennevin, Elizabeth ^a  

^a CNRS   (France)

Author keywords

Acetylcholine neurotransmission; Chronic low level exposure; DFP; Irreversible cholinesterase inhibitor; Rat; Sleep waking states; Time course of changes during dosing and after withdrawal

Indexed keywords

CHOLINESTERASE INHIBITOR; DYFLOS;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; ISOFLUROPHATE; MALE; RATS; RATS, WISTAR; SLEEP; SLEEP, REM; TIME FACTORS; WAKEFULNESS;

EID: 0032857870     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00068-4     Document Type: Article

References (52)

1. Appleyard M.E. Secreted acetylcholinesterase. Non-classical aspects of a classical enzyme Trends Neurosci. 15:1992;485-490.
2. Baghdoyan H.A. Cholinergic mechanisms regulating REM sleep. Schwartz W.J. Sleep science. Integrating basic research and clinical practice:1997;88-116 Karger, Basel.
3. Baghdoyan H.A., Monaco A.P., Rodrigo-Angulo L., Assens F., McCarley R.W., Hobson J.A. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J. Pharmacol. Exp. Ther. 231:1984;173-180.
4. Berkowitz A., Sutton L., Janowsky D.S., Gillin J.C. Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers. Psychiatr. Res. 33:1990;113-119.
5. Björklund M., Jäkälä P., Schmidt B., Riekkinen M., Koivisto E., Riekkinen P. An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats. Neuroreport. 7:1996;1097-1101.
6. Bushnell P.J., Padilla S.S., Ward T., Pope C.N., Olszyk V.B. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J. Pharmacol. Exp. Ther. 256:1991;741-750.
7. Chippendale T.J., Zawolkow G.A., Russell R.W., Overstreet D.H. Tolerance to low acetylcholinesterase levels. Modification of behavior without acute behavioral change Psychopharmacologia. 26:1972;127-139.
8. Chouvet C., Odet P., Valatx J.L., Pujol J.F. An automatic sleep classifier for laboratory rodents. Waking Sleep. 4:1980;9-31.
9. Datta S., Siwek D.F. Excitation of the brainstem pedunculopontine tegmentum cholinergic cells induces wakefulness and REM sleep. J. Neurophysiol. 77:1997;2975-2988.
10. Descarries L., Gisiger V., Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog. Neurobiol. 53:1997;603-625.
11. Deurveilher S., Hars B., Hennevin E. Pontine microinjection of carbachol does not reliably enhance paradoxical sleep in rats. Sleep. 20:1997;593-607.
12. Deurveilher S., Hars B., Hennevin E. Paradoxical sleep (PS) deprivation as a probe for evaluating PS propensity following different manipulations of cholinergic activity in rats. Soc. Neurosci. Abstr. 24:1998;1431.
13. Domino E.F., Yamamoto K.I. Nicotine. Effect on the sleep cycle of the cat Science. 150:1965;637-638.
14. Ebert U., Oertel R., Wesnes K.A., Kirch W. Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance. Hum. Psychopharmacol. 13:1998;199-210.
15. El Mansari M., Sakai K., Jouvet M. Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats. Exp. Brain Res. 76:1989;519-529.
16. Fernando J.C., Hoskins B., Ho I.K. Effect on striatal dopamine metabolism and differential motor behavioral tolerance following chronic cholinesterase inhibition with diisopropylfluorophosphate. Pharmacol. Biochem. Behav. 20:1984;951-957.
17. Garrone B., Luparini M.R., Tolu L., Magnani M., Landolfi C., Milanese C. Effect of the subchronic treatment with the acetylcholinesterase inhibitor heptastigmine on central cholinergic transmission and memory impairment in aged rats. Neurosci. Lett. 245:1998;53-57.
18. Gnadt J.W., Pegram G.V., Baxter J.F. The acetylcholinesterase inhibitor Di-Isopropyl-Fluorophosphate increases REM sleep in rats. Physiol. Behav. 35:1985;911-916.
19. Gordon C.J. Acute and delayed effects of diisopropyl fluorophosphate on body temperature, heart rate, and motor activity in the awake, unrestrained rat. J. Toxicol. Environ. Health. 39:1993;247-260.
20. Gordon C.J. 24-hour control of body temperature in the rat. II. Diisopropyl fluorophosphate-induced hypothermia and hyperthermia Pharmacol. Biochem. Behav. 49:1994;747-754.
21. Greenfield S.A. A noncholinergic action of acetylcholinesterase (AChE) in the brain. From neuronal secretion to the generation of movement Cell. Mol. Neurobiol. 11:1991;55-77.
22. Hollingsworth P.J. Chronic treatment with cholinesterase inhibitors increases alpha2-adrenoceptors in rat brain. Eur. J. Pharmacol. 153:1988;167-173.
23. Jones B. The organization of central cholinergic systems and their functional importance in sleep waking states. Cuello A.C. Progress in brain research. 1993;61-71 Elsevier Science Publishers, New York.
24. Jones B.E., Mühlethaler M. Cholinergic and GABAergic neurons of the basal forebrain. Role in cortical activation Lydic R., Baghdoyan H.A. Handbook of behavioural state control. Cellular and molecular mechanisms:1999;213-233 CRC Press, Boca Raton, FL.
25. Kayama Y., Ohta M., Jodo E. Firing of "possibly" cholinergic neurons in the rat laterodorsal tegmental nucleus during sleep and wakefulness. Brain Res. 569:1992;210-220.
26. Kodama T., Takahashi Y., Honda Y. Enhancement of acetylcholine release during paradoxical sleep in the dorsal tegmental field of the cat brain stem. Neurosci. Lett. 114:1990;277-282.
27. Leonard T.O., Lydic R. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J. Neurosci. 17:1997;774-785.
28. Lim D.K., Porter A.B., Hoskins B., Ho I.K. Changes in ACh levels in the rat brain during subacute administration of diisopropylfluorophosphate. Toxicol. Appl. Pharmacol. 90:1987;477-489.
29. Marrosu F., Portas C., Mascia M.S., Casu M.A., Fa M., Giagheddu M., Imperato A., Gessa G.L. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res. 671:1995;329-332.
30. McCarley R.W., Greene R.W., Rainnie D., Portas C.M. Brainstem neuromodulation and REM sleep. Semin. Neurosci. 7:1995;341-354.
31. Moser V.C. Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Neurotoxicol. Teratol. 17:1995;617-625.
32. Mundy W.R., Ward T.R., Dulchinos V.F., Tilson H.A. Effect of repeated organophosphate administration on carbachol-stimulated phosphoinositide hydrolysis in the rat brain. Pharmacol. Biochem. Behav. 45:1993;309-314.
33. Potter P.E., Hadjiconstantinou M., Rubenstein J.S., Neff N.H. Chronic treatment with diisopropylfluorophosphate increases dopamine turnover in the striatum of the rat. Eur. J. Pharmacol. 106:1985;607-611.
34. Riekkinen P., Riekkinen M., Sirviö J. Effects of nicotine on neocortical electrical cortical activity in rats. J. Pharmacol. Exp. Ther. 267:1993;776-784.
35. Riemann D., Gann H., Dressing H., Müller W.E., Aldenhoff J.B. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psychiatr. Res. 51:1994;253-267.
36. Riemann D., Lis S., Fritsch-Montero R., Meier T., Krieger S., Hohagen F., Berger M. Effect of tetrahydroaminoacridine on sleep in healthy subjects. Biol. Psychiatry. 39:1996;796-802.
37. Rouanet H., Bernard J.M., Leroux B. Statistiques en sciences humaines. Analyse inductive des données:1990;Dunot, Paris.
38. Russell R.W., Carson V.G., Booth R.A., Jenden D.J. Mechanisms of tolerance to the anticholinesterase, DFP. Acetylcholine levels and dynamics in the rat brain Neuropharmacology. 20:1981;1197-1201.
39. Russell R.W., Overstreet D.H. Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds. Prog. Neurobiol. 28:1987;97-129.
40. Salín-Pascual R.J., Drucker-Colín R. A novel effect of nicotine on mood and sleep in major depression. Neuroreport. 9:1998;57-60.
41. Salín-Pascual R.J., Nieto-Caraveo A., Roldán-Roldán G., Huerto-Delgadillo L., Granados-Fuentes D. Effects of physostigmine infusion on healthy volunteers deprived of rapid eye movement sleep. Sleep. 12:1989;246-253.
42. Semba K. The mesopontine cholinergic system. A dual role in REM sleep and wakefulness Lydic R., Baghdoyan H.A. Handbook of behavioural state control. Cellular and molecular mechanisms:1999;161-180 CRC Press, Boca Raton, FL.
43. Shiromani P.J., Fishbein W. Continuous pontine cholinergic microinfusion via mini-pump induces sustained alterations in rapid eye movement (REM) sleep. Pharmacol. Biochem. Behav. 25:1986;1253-1261.
44. Sitaram N., Wyatt R.J., Dawson S., Gillin J.C. REM sleep induction by physostigmine infusion during sleep. Science. 191:1976;1281-1283.
45. Sivam S.P., Norris J.C., Lim D.K., Hoskins B., Ho I.K. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum. J. Neurochem. 40:1983;1414-1422.
46. Steriade M., Curro Dossi R., Nunez A. Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves. Cortically induced synchronization and brainstem cholinergic suppression J. Neurosci. 11:1991;3200-3217.
47. Steriade M., Curro Dossi R., Paré D., Oakson G. Fast oscillations (20-40 Hz) in thalamocortical systems and their potentiation by mesopontine cholinergic nuclei in the cat. Proc. Natl. Acad. Sci. USA. 88:1991;4396-4400.
48. Steriade M., Datta S., Paré D., Oakson G., Curro Dossi R. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci. 10:1990;2541-2559.
49. Sutin E.L., Shiromani P.J., Kelsoe J.R., Storch F.I., Gillin J.C. Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatment. Life Sci. 39:1986;2419-2427.
50. Testylier C., Dykes R.W. Acetylcholine release from frontal cortex in the waking rat measured by microdialysis without acetylcholinesterase inhibitors. effects of diisopropylfluorophosphate Brain Res. 740:1996;307-315.
51. Thakkar M., Portas C., McCarley R.W. Chronic low-amplitude electrical stimulation of the laterodorsal tegmental nucleus of freely moving cats increases REM sleep. Brain Res. 723:1996;223-227.
52. Williams J.A., Comisarow J., Day J., Fibiger H.C., Reiner P.B. State-dependent release of acetylcholine in rat thalamus measured by in vivo microdialysis. J. Neurosci. 14:1994;5236-5242.